期刊名称：BLOOD TRANSFUSION
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Blood Transfusion (La Trasfusione del Sangue) is a quarterly Journal founded in 1956 by the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). It is the official journal of SIMTI and of the Associazione Italiana dei Centri Emofilia (AICE), the Hellenic Society of Blood Transfusion (HSBT), the Sociedad Española de Transfusión Sanguínea y Terapia Celular (SETS) and the Associação Portuguesa de Imuno-Hemoterapia (APIH).
It publishes Editorials, Reviews, State-of-the-Art Reports, Original Articles, Case Reports, Letters to the Editor, Book Reviews, Forums and Debates on all topics related to Transfusion Medicine, e.g.: transfusion clinical practice, immunohaematology, blood component collection and production, transfusion-transmissible diseases, immunogenetics, histocompatibility, transplantation, medical-legal correlations, biotechnology and connected molecular biology.
The print version of Blood Transfusion is published in English only. Authors' opinions may not necessarily reflect those of SIMTI or Editorial Board of Blood Transfusion.
Instructions to Authors
All manuscripts should be submitted online. Manuscripts submitted via fax or by e-mail will not be considered.
If you cannot submit online please contact the Editorial Office:
Luisa Stea, SIMTI Servizi Srl,
Via Desiderio 21, 20121 Milano, Italy
Tel.: + 39 02 23.95.11.19, Fax: + 39 02 23.95.16.21,
e-mail: luisa.stea@bloodtransfusion.it
For any information about manuscript composition, Authors should refer to papers previously published in Blood Transfusion or contact the Editorial Office. Useful guidelines are given at the site www.icmje.org .
Once an article has been submitted, the corresponding author will receive an e-mail indicating the submission number.
Please make sure that you cite your submission number in all correspondence with the Editor or Editorial Office. If the editing style does not comply with the instructions published in Blood Transfusion, the Author will be notified and asked to revise the paper before it is sent out for peer-review.
Editorials, Reviews and State-of-Art Reports are usually solicited by the Journal Board, although unsolicited Review Articles may be submitted and are subject to peer-review.
How to prepare a manuscript for submission
Each manuscript must be original work never published before in any substantial part; it must be submitted solely to Blood Transfusion and should not be under consideration for publication elsewhere. Meeting or Congress Abstracts and Lectures are not considered as prior publications.
If a manuscript is accepted, all copyrights, including the right to reproduce all or part of the manuscript, will be assigned exclusively to the Publisher, i.e. SIMTI Servizi Srl. The terms for copyright, authorship and financial disclosure must be accepted when submitting an article.
Language
All manuscripts must be written in English (British English).
Italian Authors can submit manuscripts in Italian. If an article in Italian is accepted, it will be translated by the Editorial Office, free of charge, and published in English.
Files
All text elements (tables included) should be submitted in one file only.
The following file types are accepted:
- Microsoft Word (.doc and .docx);
- generic Rich Text Format (RTF).
Authorship declaration, Copyright release and Conflict of Interest disclosure
Please accept online the terms for:
- Copyright;
- Authorship;
- Financial Disclosure.
If there is any possible conflict of interest, the Author(s) should describe it fully; the text will be automatically printed in the Authorship Declaration to be signed and returned to the Editorial Office.
Examples: "NAME is collaborating with XXX industry for research in the field" or "NAME will speak about this issue in a sponsored symposium of XXX industry".
Authorship declaration, Copyright release and Conflict of Interest disclosure (declaration.pdf) are automatically e-mailed to the corresponding author upon manuscript submission and should be signed and returned to the Editorial Office by fax (+39 02 23.95.16.21) or e-mail to luisa.stea@bloodtransfusion.it. The Author who submits a paper for publication is responsible that all other Authors agree to its submission and to its content.
Funding and resources
Institutional, research, private or any other funds and resources, totally or partially used to carry out the original work, must be declared.
The first page of the submitted article must contain:
1) title of the article;
2) names of Authors (full first name and surname);
3) institutions;
4) a running title of no more than 60 characters (including spaces);
5) keywords: Original Articles, Case Reports and Reviews require 3-5 keywords to be entered into the field;
6) corresponding author (full address and e-mail).
From the second page
Abstract: Original Articles require an Abstract of no more than 2,000 characters (including spaces), structured as follows:
- Background;
- Materials and methods;
- Results;
- Discussion.
The abstract should be sufficiently explanatory of the whole paper and should only include text, without any abbreviations or citations.
- Chapters. Original Articles must be organised into the following chapters: Introduction, Materials and methods, Results, Discussion/Conclusions, Acknowledgements (if any) and References. Long articles may need subheadings to clarify some sections, such as Materials and methods, Results and Discussion.
- Case Reports must be concise and divided into Introduction, Case report with Result(s), Discussion and References.
- Letters to the Editor must not exceed 1,500 words with a maximum of 5 References.
All measurements should be expressed in the International System of Units (SI); please see also www.bloodtransfusion.it for further and more complete information. Abbreviations should be spelled out on their first use in the text (unless it is a standard abbreviation or a unit of measurement) and thereafter applied consistently throughout the manuscript. The first time any equipment, apparatus or reagent is used, the name of the manufacturer(s) (and identifying address) must be provided in parentheses.
Red cell group terminology should follow the conventions outlined in the report by Garratty et al. (Transfusion 2000; 40: 477-89), while the nomenclature for factors of the HLA system should follow the convention outlined in the report by Bodmer JG et al. (Vox Sang 1999; 77: 164-91). Granulocyte antigens should be named according to the convention described in the publication by ISBT Granulocyte Antigen Working Party (Vox Sang 1999; 77: 251, with the clarification of Lalezari in Transfusion 2002; 42: 1396-7), and the nomenclature of platelet-specific antigens should follow the convention outlined in von dem Borne & Decary (Transfusion 1990; 30: 477).
- Tables, collected at the end of the manuscript, must have a brief title and a legend and must be numbered consecutively in the same order as they are first cited in the text, using upper case Roman numbers. All explanatory information should be placed in a legend at the bottom of the table and not in the heading. Each Table must be cited in the text.
- Illustrations include figures, photographs and graphics. Each figure must be supplied as a separate file from the text file; only .jpg, .bmp, .gif and .tif formats, with a resolution of at least 300 dpi (dots per inch), maximum size 10 MB, can be used. Artwork in other format is not acceptable. Please note that images downloaded from the Internet generally have a resolution of 72 dpi only and are therefore unsuitable for conventional printing purposes. Please do not increase their resolution manually. Illustrations must be numbered progressively according to their order of appearance in the text, using Arabic numbers. Each Figure must be cited in the text. The illustration's title and a short legend, if necessary, must be entered into the field "Title/legend" (ex. "Figure 1 - Algorithm for the diagnosis of thrombocytopenias"). Illustrations will be printed in black and white. Please do not use Microsoft Organization Chart application to create figures, graphics or tables.
References. Only strictly relevant references must be quoted in the reference list at the end of the manuscript. They should be numbered consecutively in the order in which they appear in the text. A reference in the text is identified as a superscripted number (without parentheses) after the text that quotes the corresponding paper listed in the reference list (e.g. blood transfusion1).
If more than one citation is required, the reference numbers in the text are separated by a comma with no space in between (e.g. blood transfusion1,3,7).
If reference numbers in the text are more than two and consecutive, only the first and the last numbers separated by a hyphen should be cited (e.g. blood transfusion1-4).
In the reference list, Journal names should be abbreviated as described in Index Medicus, Medline and Pubmed. Abbreviations can also be obtained from http://www.nlm.nih.gov/tsd/serials/lsiou.html website.
The names of up to four authors should be listed. If a reference has five or more authors, only the first three should be listed, followed by "et al.".
Personal communications, unpublished observations, and manuscripts that have been "submitted" or are "in preparation" must be cited in the text, but not included in the reference list.
Only papers accepted for publication can be included in the reference list, even if they are not published, yet. In this case, add the DOI number.
References must be written in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals published by the International Committee of Medical Journal Editors (www.icmje.org). Some examples are given below:
Citation from a Journal article
- Hess JR [without punctuation marks after the initial(s) of the first name], Hill HR, Oliver CK, et al. Alkaline CPD and the preservation of RBC 2,3-DPG. Transfusion 2002; 42 [bold-type]: 747-52.
Citation from a Journal article published online ahead of print
- Hess JR [without punctuation marks after the initial(s) of the first name], Hill HR, Oliver CK, et al. Alkaline CPD and the preservation of RBC 2,3-DPG. Transfusion 2002; DOI xx2001-xxx10001.x.
Citation from a Book
- Issitt PD, Anstee DJ. (punctuation mark between authors and title) Applied Blood Group Serology. [title of the book in italics with the first letter of all words in capitals, except prepositions such as 'the', 'of', 'about' etc.) in capitals] 4th ed. Durham, NC: Montgomery Scientific Publications; 1998.
Citation of a Chapter in a book
- Beatty PG. The molecular revolution in histocompatibility testing: relevance to blood and marrow transplantation. In: Garratty G, editor. Application of Molecular Biology to Blood Transfusion. Bethesda, MD: American Association of Blood Banks (or AABB); 1997. p. 51-72. [If there are five or more Editors, list only the first three and add "et al."].
Citation of an Editorial
- Garratty G, Petz LD. Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia [editorial]. Transfusion 2002; 42: 1390-2.
Citation of an Abstract
- Kleinman SH, Stramer SL, Mimms L, et al. Comparison of preliminary observed yield of HCV and HIV minipool (MP) nucleic acid testing (NAT) with prediction from incidence/window period (inc/wp) model [abstract]. Transfusion 2000; 40 (Suppl 1): ABS010.
Citation of a Paper Conference
- Anderson JC. Current status of chorion villus biopsy. In: Tudenhope D, Chenoweth J, editors. Proceedings of the 4th Congress of the Australian Perinatal Society; 1986: Brisbane, Queensland: Australian Perinatal Society; 1987. p. 190-6.
Citation of a Letter
- Jimenez M, Sanz C, Alvarez A, Pereira A. Massive intravascular haemolysis in a patient with Clostridium perfrigens sepsis [letter]. Vox Sang 2002; 82, 214.
Citation of Electronic material
- A concept paper on prestorage leukocyte reduction of transfusion blood components. Food and Drug Administration. Available at: http//www.fda-gov/ohrms/dockets/ac/00/backgrd/3620b2,doc., followed by "Accessed on dd/mm/yyyy" (the date when the paper was downloaded from the website).
Peer review
All submissions are subject to peer-review by two experts selected by the Editor-in-Chief and the Associate Editors.
The referees' comments are returned to the Authors, who may be asked to revise their submission. Authors who resubmit a revised version must log in again into the Blood Transfusion website and replace the file of the manuscript according to the referees' criticism and the e-mail received. Authors who do not agree with the referees' criticism must clearly state their reasons. It is up to the Editors to accept such reasons.
A copy of the manuscript with highlighted changes in the text may be convenient in order to help speed the review process. Revised papers are reviewed by the original referees, unless the Editor-in-Chief opts for an immediate decision. Acceptance of a revised paper is not granted but contingent on the acceptability of the changes made in compliance with the referees' criticisms.
The final decision on a paper's acceptability for publication is made by the Editor-in-Chief on the basis of the comments of an Associate Editor and the referees.
Online pre-publication
As soon as a paper is accepted, edited and corrected, it is posted online in its definitive version (pdf format), at www.bloodtransfusion.it before being assigned to a print issue.
Online pre-publication allows accepted articles to be visible and indexed 3-6 months earlier than the print publication date. The early online date counts as the official publication date. To this purpose a Digital Object Identifier (DOI) number is assigned to the online article to allow the pre-published article to be cited well before its appearance in print.
Alert service
Please note that your e-mail address will be included in the Blood Transfusion free alert service, to receive e-mail notification when new articles are published.
Galley proofs
Galley proofs are sent to the Corresponding Authors for approval and corrections. They must be returned to the Editorial Office within 1 week. Major alterations to the text are not accepted at a proof stage. Please keep a copy of the corrected galley pages. Reprints may be requested by the Corresponding Author.
Address
Blood Transfusion publishes the corresponding Author's e-mail and full postal address in the Journal.
Ethical concerns
In case of experimental/clinical reports involving patients or volunteers, the Authors must provide information about institutional, regulatory and ethical Committee authorisation, informed consent from patients and volunteers, and the observance of the latest release of the Helsinki Declaration (http://www.wma.net/en/30publications/10policies/b3/index.html).
The International System (IS) of units of measurement must be adopted, using prefixes and symbols as follows.
Prefix Factor Symbol
exa 1018 E
peta 1015 P
tera 1012 T
giga 109 G
mega 106 M
kilo 103 k
hecto 102 h
deka 101 da
deci 10-1 d
centi 10-2 c
milli 10-3 m
micro 10-6 m
nano 10-9 n
pico 10-12 p
femto 10-15 f
atto 10-18 a
Concentration Units
molar M
mole mol
normal N
molality molal
Length Units
micrometre µm (not m)
ångström Å
metre m
nanometre nm (not mm)
Volume Units
litre L
millilitre mL
decilitre dL
microlitre mL (not l)
Mass Units
kilogram kg
decigram dg
gram g
microgram mg (no g)
Time Units
second s
day day
minute min
week week
hour h
month month
Electric Current Units
ampere A
volt V
ohm W
watt W
Statistical Terms
analysis of variance ANOVA
not tested NT
coefficient of variation CV
not significant NS
confidence interval CI
probability p
correlation coefficient r
standard error SE
degrees of freedom df
Student t test t-test
Principal Abbreviations
2,3 BPG 2,3 biphosphoglycerate acid
2-ME 2-mercaptoethanol
5-Ht 5-hydroxytryptamine (not serotonin)
ACD-2 acid citrate dextrose-2
ADP adenosine diphosphate
AIDS acquired immune deficiency syndrome
ALT alanine aminotransferase
AST aspartase aminotransferase
BFU-E burst-forming unit-erythroid
BMT bone marrow transplantation
bp base pair
BSE bovine spongiform encephalopathy
BSA bovine serum albumin
C Complement
°C degrees Celsius
CCI correct count increment
CD cluster designation
CDC Centers for Disease Control and Prevention
cDNA complementary DNA
CFU colony-forming unit
CFU-G colony-forming unit-granulocyte
Ci Curie
CJD Creutzfeldt-Jakob disease
CMV cytomegalovirus
CO cut-off
CPD citrate phosphate dextrose
CPD-A citrate phosphate dextrose-adenine
cpm counts per minute
cps counts per second
CSF colony-stimulating factor
Da Daltons
DAT direct antiglobulin test
DMSO dimethylsulphoxide
DNA deoxyribonucleic acid
DTT dithiothreitol
EBV Epstein-Barr virus
EDTA ethylenediaminetetracetate
EIA enzyme immunoassay
ELISA enzyme-limked immunosorbent assay
Eq Equivalent
F(ab) antigen-binding fragment
FBS foetal bovine serum
FCS foetal calf serum
FDA Food and Drug Administration
FFP fresh-frozen plasma
FITC fluorescein isothiocyanate
G-6-PD glucose-6-phosphate dehydrogenase
g force of gravity
G-CSF granulocyte-colony stimulating factor
GP glycoprotein
GPA glycophorin A
GPB glycophorin B
GPC glycophorin C
GPD glycophorin D
GvHD Graft-versus-host disease
Gy Gray radiation(s)
HAV hepatitis A virus
Hb haemoglobin
HBc hepatitis B core antigen
HBsAg hepatitis B surface antigen
HBSS Hanks balanced salt solution
HBV hepatitis B virus
Hct haematocrit
HCV hepatitis C virus
HDN haemolytic disease of the newborn
HES hydroxyethyl starch
HGV hepatitis G virus
HHV human herpes virus
HIV-1 human immunodeficiency virus, type 1
HIV-2 human immunodeficiency virus, type 2
HLA human leucocyte antigen(s)
HNA human granulocyte antigen(s)
HPA human platelet antigen(s)
HSA human serum albumin
HPC(s) haematopoietic progenitor cell(s)
HTLV-I human T-lymphotropic virus, type I
HTLV-II human T-lymphotropic virus, type II
IAT indirect antiglobulin test
IFN interferon
IgA immunoglobulin A
IgD immunoglobulin D
IgE immunoglobulin E
IgG immunoglobulin G
IgM immunoglobulin M
IL interleukin (a number follows)
IM intramuscular
ISBT International Society of Blood Transfusion
IU International Unit
IV intravenous
IVIG intravenous immune globulin
kb kilobase
kDa kilodalton
LDH lactate dehydrogenase
LISS low-ionic-strength solution
MCHC mean cell (RBC) Hb concentration
M-CSF macrophage colony-stimulating factor
MCV mean cell (RBC) volume
MHC major histocompatibility complex
MNC(s) mononuclear cell(s)
MoAb monoclonal antibody
mRNA messenger RNA
NA neutrophil antigen(s)
NAT nucleic acid amplification testing
NIH National Institutes of Health
NK natural killer (cells)
OD optical density
OR odds ratio
PAGE polyacrylamide gel electophoresis
PBS phosphate-buffered saline
PBSC(s) peripheral blood stem cell(s)
pCO2 partial pressure of CO2
PCR polymerase chain reaction
PEG polyethylene glycol
pH negative logarithm
of hydrogen ion concentration
PHA phytohaemagglutinin A
PMN(s) polymorphonuclear leucocyte(s)
pO2 partial pressure of O2
PrP(sc) prion protein (scrapie)
PrP(c) prion protein (cellular)
PVC polyvinylchloride
QC quality control
R Röntgen radiation(s)
Rad radiation absorbed dose
RBC(s) red blood cell(s)
RFLP restriction fragment length polymorphism
RHu recombinant human
RIA radioimmunoassay
RIBA recombinant immunoblot assay
RNA ribonucleic acid
rpm revolutions per minute
s sedimentation coefficient
S Svedberg unit of sedimentation (10-13 s)
SCID severe combined immunodeficiency
SDS sodium dodecylsulphate
S/D solvent/detergent
TNFa tumour necrosis factor a
TRALI transfusion-related acute lung injury
tRNA transfer RNA
UTR untranslated region
UV ultraviolet
vCJD variant Creutzfeldt-Jacob disease
VNTR variable number of tandem repeats
vWD von Willebrand’s disease
vWF von Willebrand factor
WBC(s) white blood cell(s)
Editorial Board
Editor-in-Chief
Claudio Velati
claudio.velati@simti.it
Associate Editors
Massimo Franchini
Giancarlo Maria Liumbruno
Daniele Prati
Roberto Reverberi
Luisa Romanò
Giuseppe Tagariello
Alberto Zanella
Affiliated Society Editors
Maria Helena Gonçalves, APIH
Pier Mannuccio Mannucci, AICE
Alice Maniatis, HSBT
Isidro Prat Arrojo, SETS
Executive Director
Stefano Antoncecchi
Founder
Lorenzo Lapponi
Past Editors-in-Chief
Lorenzo Lapponi, 1956 - 1964
Carlo Alberto Lang, 1965-1966
Roberto Venturelli, 1967-1968
Rosalino Sacchi, 1969- 1978
Giorgio Reali, 1979-2006
International Editorial Board
Jean Pierre Allain, United Kingdom
Giuseppe Aprili, Italy
Michele Baccarani, Italy
John Barbara, United Kingdom
Franco Biffoni, Italy
Pietro Bonomo, Italy
Dialina Brilhante, Portugal
Maria Domenica Cappellini, Italy
Jean-Pierre Cartron, France
Alberto Catalano, Italy
Roberto Conte, Italy
Francine Décary, Canada
Giovanni de Gaetano, Italy
Willy A. Flegel, United States
Salvatore Formisano, Italy
Gabriella Girelli, Italy
Giuliano Grazzini, Italy
Antonio Iacone, Italy
Pasquale Iacopino, Italy
Giancarlo Icardi, Italy
Syria Laperche, France
Luis Larrea, Spain
Franco Locatelli, Italy
Mike Makris, United Kingdom
Aurelio Maggio, Italy
Anna Lucia Massaro, Italy
Eduardo Muñiz-Diaz, Spain
Mario Muon, Portugal
Alessandro Nanni Costa, Italy
Salvador Oyonarte, Spain
Arturo Pereira, Spain
Paolo Rebulla, Italy
Philippe Rouger , France
Paul FW Strengers, The Netherlands
Cees L van der Poel, The Netherlands
Alessandro Zanetti, Italy
Editorial Office Manager
Luisa Stea
SIMTI Servizi Srl
Via Desiderio 21 - 20131 Milano
Tel.: +39 02 23951119 (ext. 3)
Fax: +39 02 23951621
luisa.stea@bloodtransfusion.it
| 
